0NHS Stock Chart & Stats
$69.73
-$0.32(-0.46%)
At close: 4:00 PM EDT
$69.73
-$0.32(-0.46%)
Day’s Range― - ―
52-Week Range$53.05 - $87.36
Previous CloseN/A
Volume568.00
Average Volume (3M)3.64K
Market Cap
$34.62B
Enterprise Value$59.67K
Total Cash (Recent Filing)$919.50M
Total Debt (Recent Filing)$12.71B
Price to Earnings (P/E)14.9
Beta0.58
Next Earnings
Nov 04, 2026EPS Estimate
0.96Next Dividend Ex-DateN/A
Dividend Yield2.98%
Share Statistics
EPS (TTM)4.87
Shares Outstanding477,210,080
10 Day Avg. Volume2,398
30 Day Avg. Volume3,636
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)1.19
Price to Sales (P/S)1.12
P/FCF Ratio14.73
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$77.07Price Target Upside10.53% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
EPS Forecast (FY)5.04
Revenue Forecast (FY)$28.03B
Bulls Say, Bears Say
Bulls Say
Potash Scale, Automation And Cost PositionNutrien’s large potash platform, record volumes and expanding automation support lower unit costs, productivity and safer operations. These advantages can strengthen resilience through fertilizer cycles and provide capacity flexibility as global nutrient demand develops.
Diversified Integrated Agriculture ModelThe combination of upstream fertilizer production and a broad retail network diversifies earnings across manufacturing, distribution and agronomic services. Retail reach and proprietary products can deepen grower relationships, support recurring demand and reduce reliance on one nutrient.
Recovering Profitability With Manageable LeverageThe rebound in revenue and margins indicates meaningful recovery from the weaker 2023–2024 period, while moderate leverage preserves financial flexibility. A stronger balance sheet gives Nutrien capacity to fund operations, maintenance and strategic investment across the cycle.
Bears Say
Weak Cash ConversionPositive cash flow remains substantial, but its sharp decline and weak conversion from earnings reduce the quality and flexibility of reported profits. If working-capital needs or capital spending stay elevated, less cash may be available for debt reduction and shareholder returns.
High Exposure To Fertilizer CyclicalityNutrien’s upstream earnings depend on global nutrient prices, farmer application rates and energy costs, creating structural volatility. The gap between current and 2022 margins shows that recovery does not eliminate the risk of future price, demand and input-cost downturns.
Phosphate Pressure And Retail Cost ChallengesElevated sulfur costs can compress phosphate profitability until pricing or sourcing conditions improve, while declining retail fertilizer volumes and higher fuel and fleet expenses pressure downstream margins. These issues may persist if input costs and grower demand remain unfavorable.
Nutrien News
0NHS FAQ
What was Nutrien Ltd’s price range in the past 12 months?
Nutrien Ltd lowest share price was $53.05 and its highest was $87.36 in the past 12 months.
What is Nutrien Ltd’s market cap?
Nutrien Ltd’s market cap is $34.62B.
When is Nutrien Ltd’s upcoming earnings report date?
Nutrien Ltd’s upcoming earnings report date is Nov 04, 2026 which is in 68 days.
How were Nutrien Ltd’s earnings last quarter?
Nutrien Ltd released its earnings results on Aug 05, 2026. The company reported $2.642 earnings per share for the quarter, missing the consensus estimate of $2.75 by -$0.108.
Is Nutrien Ltd overvalued?
According to Wall Street analysts Nutrien Ltd’s price is currently Undervalued.
Does Nutrien Ltd pay dividends?
Nutrien Ltd pays a Quarterly dividend of $0.552 which represents an annual dividend yield of 2.98%. See more information on Nutrien Ltd dividends here
What is Nutrien Ltd’s EPS estimate?
Nutrien Ltd’s EPS estimate is 0.96.
How many shares outstanding does Nutrien Ltd have?
Nutrien Ltd has 477,210,080 shares outstanding.
What happened to Nutrien Ltd’s price movement after its last earnings report?
Nutrien Ltd reported an EPS of $2.642 in its last earnings report, missing expectations of $2.75. Following the earnings report the stock price went down -0.794%.
Which hedge fund is a major shareholder of Nutrien Ltd?
Currently, no hedge funds are holding shares in GB:0NHS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nutrien Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$77.07 (10.53% Upside)
$77.07 (10.53% Upside)
Blogger Sentiment
Bullish
GB:0NHS Sentiment 67%
Sector Average 61%
Sector Average 61%
Insider Transactions
Bought Shares
Worth $174.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
16.89%
12-Months-Change
Fundamentals
Return on Equity
2.98%
Trailing 12-Months
Asset Growth
0.56%
Trailing 12-Months
Company Description
Nutrien Ltd
Nutrien Ltd. is a prominent agricultural company dedicated to supplying crucial crop inputs and comprehensive services to the farming sector. It specializes in the production and provision of essential plant nutrients like potash, nitrogen, phosphate, and sulfate, alongside offering financial support to its clientele. The company leverages an expansive retail footprint of roughly 2,000 locations across the United States, Canada, South America, and Australia to distribute a full spectrum of agricultural products, including fertilizers, crop protection solutions, seeds, and various merchandise. Furthermore, Nutrien directly assists growers through a network of farm centers strategically placed throughout North America, South America, and Australia. The company, established in 2017, maintains its corporate headquarters in Saskatoon, Canada.
0NHS Company Deck
0NHS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a generally positive tone: the company achieved record potash volumes, modest EBITDA growth (+6% H1), stronger cash flow (+12% H1), successful operational execution (automation, major turnaround), and increased shareholder returns (capex reduction and stepped-up buybacks). Offsetting items include notable weakness in phosphate margins from soaring sulfur costs, lower retail fertilizer volumes (phosphate down ~10%, nitrogen down ~7% in downstream), higher retail SG&A (fuel/fleet), seed profit weakness, and continuing geopolitical and weather-related market uncertainties. On balance, the strengths in operations, cash generation and capital allocation outweigh the challenges described.View all GB:0NHS earnings summaries0NHS Stock 12 Month Forecast
Average Price Target
$77.07
▲(10.53% Upside)
Technical Analysis
Bee Vectoring Technologies International
―
Karnalyte Resources
―
Verde Agritech
―
Itafos
―
MustGrow Biologics
―